Search details
1.
COVID-19 and pregnancy: A European study on pre- and post-infection medication use.
Eur J Clin Pharmacol
; 80(5): 707-716, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38347228
2.
COVID-19-related medicine utilization study in pregnancy: The COVI-PREG cohort.
Br J Clin Pharmacol
; 89(5): 1560-1574, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36417423
3.
Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs.
Eur J Clin Pharmacol
; 75(4): 577-586, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30596208
4.
Estimating the national carbon footprint of inhalers in healthcare.
Ir J Med Sci
; 192(5): 2251-2253, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-36482282
5.
Formal health care costs among older people in Ireland: methods and estimates using The Irish Longitudinal Study on Ageing (TILDA).
HRB Open Res
; 6: 16, 2023.
Article
in English
| MEDLINE | ID: mdl-37829548
6.
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping Review.
J Clin Med
; 12(13)2023 Jul 06.
Article
in English
| MEDLINE | ID: mdl-37445553
7.
Rationalising Antipsychotic Prescribing in Dementia (RAPID) complex intervention: A mixed-methods feasibility intervention study.
Explor Res Clin Soc Pharm
; 8: 100190, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36277309
8.
Deciphering patterns of respiratory medication use in Ireland to target interventions appropriately: a focus on COPD.
Ir J Med Sci
; 190(3): 1103-1109, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33089418
9.
Developing a complex intervention targeting antipsychotic prescribing to nursing home residents with dementia.
HRB Open Res
; 4: 23, 2021.
Article
in English
| MEDLINE | ID: mdl-34136749
10.
Pharmacist-led academic detailing intervention in primary care: a mixed methods feasibility study.
Int J Clin Pharm
; 41(2): 574-582, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30666611
11.
Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis.
J Manag Care Spec Pharm
; 25(1): 113-121, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30589630
Results
1 -
11
de 11
1
Next >
>>